Clinical trial Recruiting at 1 site Observational Ages 18 to 75

Understanding how aging affects blood vessel health and heart disease

Official title: Cellular and Molecular Mechanisms of Vascular Senescence and atherosclerotIC Plaque Vulnerability: the TelOmere-mitochondRIa Cross-tAlk Study

Run by Niguarda Hospital · NCT06313645 · Data updated 2026-11-12

This study looks at how getting older affects blood vessel health and heart disease in people with different heart conditions to find ways to improve their treatment.

More Coronary Artery Disease trials

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment300 (estimated)
SponsorNiguarda Hospital
Academic / other
Locations1 site (Milan, Lombardy)
StatusRecruiting
StartedJuly 1, 2023
Main results expectedJuly 1, 2026
Study endsDecember 31, 2027
Registry record updatedApril 16, 2026
Trial IDNCT06313645 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients experiencing acute coronary syndromes or stable angina.

Probably not a fit

Patients with severe conditions such as cardiac shock, congestive heart failure, or active cancer may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the role of vascular senescence and DNA damage in the development of coronary artery disease. It aims to explore how chronological aging and environmental factors contribute to vascular deterioration and atherosclerosis. By analyzing biomarkers related to DNA damage and cellular senescence, the study seeks to identify potential therapeutic targets to mitigate the effects of vascular aging. Participants will include patients with various forms of acute coronary syndromes and stable angina.

Why it matters

Potential benefit: If successful, this study could lead to new strategies for preventing or treating coronary artery disease by targeting the mechanisms of vascular aging.

How similar studies have gone: Other studies have shown promising results in understanding the mechanisms of vascular aging and its impact on heart disease, suggesting that this approach is both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with acute coronary syndromes (unstable angina, non-ST segment elevation myocardial infarction (NSTEMI), ST segment elevation myocardial infarction (STEMI))
* stable angina
* non-angiographically significant coronary diseases recovered for elective diagnostic or interventional procedures

Exclusion Criteria:

* cardiac shock
* congestive heart failure
* end stage renal diseases
* coronary artery bypass graft
* active cancer

Where it's running

  • ASST GOM Niguarda
    Milan, Lombardy, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.